This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Haowen Jiang: Innovator in Cancer Treatment
Introduction
Haowen Jiang is a prominent inventor based in Stanford, California. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on enhancing the effectiveness of differentiation therapy for cancer cells.
Latest Patents
Haowen Jiang holds a patent titled "Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine." This patent outlines methods for treating cancer by administering a mitochondrial uncoupler in a dose effective to increase the differentiation of cancer cells. The treatment may be combined with retinoic acid to further enhance the differentiation process. The effects on targeted cancer cells are significantly improved compared to regimens using a single agent, and the results may be synergistic, particularly in cases where cancer cells are resistant to retinoic acid.
Career Highlights
Jiang is affiliated with Leland Stanford Junior University, where he conducts his research and develops his innovative treatments. His work has garnered attention for its potential to improve cancer therapies and patient outcomes.
Collaborations
Haowen Jiang collaborates with notable colleagues, including Jiangbin Ye and Yang Li. Their combined expertise contributes to advancing research in cancer treatment and therapeutic methods.
Conclusion
Haowen Jiang's innovative approach to cancer treatment through his patented methods showcases his dedication to improving patient care. His contributions to the field are significant and hold promise for future advancements in cancer therapy.